Unveiling Pharmaceutical Industry's Unethical Practices

Exploring the corrupt practices within the pharmaceutical industry, this chapter sheds light on issues like the opioid crisis, AIDS-infected blood sales, and the collusion between companies, governments, and global entities. It discusses scandals involving high-profile figures, lack of accountability, and the prioritization of profits over patient safety, underscoring the urgent need for justice and change. The narrative challenges societal values, questions regulatory systems' integrity, and emphasizes the importance of independence from pharmaceutical influence for public health.